On February 5, 2024, the company’s Board of Directors authorized a $500M repurchase program of the company’s Class A common stock. This authorization replaces the existing repurchase program authorized on April 25, 2022.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PJT:
- Is PJT a Buy, Before Earnings?
- PJT Partners resumed with a Market Perform at Keefe Bruyette
- PJT Partners downgraded to Neutral from Buy at Goldman Sachs
- PJT Partners downgraded to Underperform from Peer Perform at Wolfe Research
- Alkermes, Armstrong World, National Healthcare, PJT Partners to join S&P 600
